United Therapeutics

YTD

ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,305

Employees1,305

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,305

Employees1,305

UTHR Key Statistics

Market cap

20.53B

Market cap20.53B

Price-Earnings ratio

18.07

Price-Earnings ratio18.07

Dividend yield

—

Dividend yield—

Average volume

327.68K

Average volume327.68K

High today

$479.41

High today$479.41

Low today

$472.69

Low today$472.69

Open price

$473.83

Open price$473.83

Volume

267.31K

Volume267.31K

52 Week high

$519.99

52 Week high$519.99

52 Week low

$266.98

52 Week low$266.98

Stock Snapshot

As of today, United Therapeutics(UTHR) shares are valued at $476.78. The company's market cap stands at 20.53B, with a P/E ratio of 18.07.

On 2026-01-28, United Therapeutics(UTHR) stock moved within a range of $472.69 to $479.41. With shares now at $476.78, the stock is trading +0.9% above its intraday low and -0.5% below the session's peak.

Trading volume for United Therapeutics(UTHR) stock has reached 267.31K, versus its average volume of 327.68K.

Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $519.99 and a low of $266.98.

UTHR News

Simply Wall St 4d

Assessing United Therapeutics Valuation After Recent Share Price Swings

Advertisement Why United Therapeutics (UTHR) is on investors’ radar today United Therapeutics (UTHR) has drawn attention after recent share price swings, with...

TipRanks 6d

United Therapeutics appoints new director, updates bylaws

Claim 50% Off TipRanks Premium United Therapeutics ( (UTHR) ) has issued an update. On January 21, 2026, United Therapeutics’ board expanded its size to 13 me...

Analyst ratings

73%

of 15 ratings

Buy

73.3%

Hold

26.7%

Sell

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.